References
- World Health Organization (WHO). Global status report on noncommunicable diseases 2014. Geneva, Switzerland: World Health Organization; 2014.
- Institute for Public Health. National Health and Morbidity Survey (NHMS). Non-communicable diseases, healthcare demand, and health literacy—key findings. Shah Alam, Malaysia: National Institutes of Health; 2020; 2019.
- Kario K, Tomitani N, Buranakitjaroen P, Chia Y-C, Park S, Chen C-H, Divinagracia R, Shin J, Siddique S, Sison J, et al. Home blood pressure control status in 2017-2018 for hypertension specialist centers in Asia: results of the Asia BP@home study. J Clin Hypertens (Greenwich). 2018;20(12):1686–95. doi:https://doi.org/10.1111/jch.13415.
- Ong SK, Kahan SZ, Lai DTC, Si-Ramlee KA, Abdullah MA, Sidup N, Kamis Z, Chong CL. Prevalence of undetected hypertension and its association with socio-demographic and non-communicable diseases risk factors in Brunei Darussalam. J Public Health (Berl). 2020. doi:https://doi.org/10.1007/s10389-020-01287-y.
- Philippine Heart Association-Council on Hypertension. Philippine heart association‐council on hypertension report on survey of hypertension (Presyon 3): a report on prevalence of hypertension, awareness and treatment profile. Phil J Cardiol. 2013;41(1):43‐48.
- Castillo RR, Atilano AA, David-Ona DI, Napiza-Granada C, Cruz-Sevilla MR, Torreblanca H, Castro R, Gomez LA, Mercado-Asis LB, Bonzon DD, et al. May measurement month 2017: an analysis of blood pressure screening in the Philippines-South-East Asia and Australasia. Eur Heart J Suppl. 2019;21(SupplD):D92–D96. doi:https://doi.org/10.1093/eurheartj/suz066.
- Epidemiology and Disease Control Division. National health survey 2010. Singapore: epidemiology and disease control division; 2011 [accessed 2020 Oct 24]. Available from: https://www.moh.gov.sg/docs/librariesprovider5/resources-statistics/reports/nhs2010—low-res.pdf
- Bureau of Policy and strategy. Thailand Health Profile. Nonthaburi. Thailand: Ministry of Public Health; 2007; 2005-2006.
- Buranakitjaroen P, Wanthong S, Sukonthasarn A.Asian management of hypertension: current status, home blood pressure, and specific concerns in Thailand. J Clin Hypertens (Greenwich). 2020;22(3):515–18. doi:https://doi.org/10.1111/jch.13800.
- Sakboonyarat B, Rangsin R, Kantiwong A, Mungthin M.Prevalence and associated factors of uncontrolled hypertension among hypertensive patients: a nation-wide survey in Thailand. BMC Res Notes. 2019;12(1):380. doi:https://doi.org/10.1186/s13104-019-4417-7.
- Son PT, Quang NN, Viet NL, Khai PG, Wall S, Weinehall L, Bonita R, Byass P. Prevalence, awareness, treatment and control of hypertension in Vietnam-results from a national survey. J Hum Hypertens. 2012;26(4):268–80. doi:https://doi.org/10.1038/jhh.2011.18.
- Beaney T, Schutte AE, Tomaszewski M, Ariti C, Burrell LM, Castillo RR, Charchar FJ, Damasceno A, Kruger R, Lackland DT, et al. May measurement month 2017: an analysis of blood pressure screening results worldwide [published correction appears in lancet glob health. 2018 may 23]. Lancet Glob Health. 2018;6(7):e736–e743. doi:https://doi.org/10.1016/S2214-109X(18)30259-6.
- Turana Y, Widyantoro B, Situmorang TD, Delliana J, Roesli RMA, Danny SS, Suhardjono, Sofiatin Y, Hermiawaty E, Kuncoro AS, et al. May measurement month 2018: an analysis of blood pressure screening results from Indonesia. Eur Heart J Suppl. 2020;22(SupplH):H66–H69. doi:https://doi.org/10.1093/eurheartj/suaa031.
- Turana Y, Tengkawan J, Soenarta AA.Asian management of hypertension: current status, home blood pressure, and specific concerns in Indonesia. J Clin Hypertens (Greenwich). 2020;22(3):483–85. doi:https://doi.org/10.1111/jch.13681.
- Pengpid S, Vonglokham M, Kounnavong S, Sychareun V, Peltzer K. The prevalence, awareness, treatment, and control of hypertension among adults: the first cross-sectional national population-based survey in Laos. Vasc Health Risk Manag. 2019;15:27–33. doi:https://doi.org/10.2147/VHRM.S199178.
- Vang C, Melanie C, Phoxay C, Thongsana S, Sombandith S, Sisamouth B, Manivong B, Boundachoundara I. Report on STEPS survey on non communicable diseases rick factors in Vientiane capital city. 2010 [accessed 2020 Oct 24]. Available from: https://www.who.int/ncds/surveillance/steps/2008_STEPS_Report_Laos.pdf
- Oum S, Prak PR, Khuon EM, Mey V, Aim S, Bounchan Y, Cin S, Pen L, Loun S. Prevalence of non-communicable disease risk factors in Cambodia. 2010 [accessed 2020 Oct 24]. Available from: https://www.who.int/ncds/surveillance/steps/2010_STEPS_Report_Cambodia.pdf
- Gupta V, LoGerfo JP, Raingsey PP, Fitzpatrick AL.The prevalence and associated factors for prehypertension and hypertension in Cambodia. Heart Asia. 2013;5(1):253–58. doi:https://doi.org/10.1136/heartasia-2013-010394.
- Bjertness MB, Htet AS, Meyer HE, Htike MMT, Zaw KK, Oo WM, Latt TS, Sherpa LY, Bjertness E. Prevalence and determinants of hypertension in Myanmar - a nationwide cross-sectional study. BMC Public Health. 2016;16(1):590. doi:https://doi.org/10.1186/s12889-016-3275-7.
- General Directorate of Statistics (GDS) and International Classification of Functioning, Disability and Health (ICF). 2016 timor-leste demographic and health survey key findings. Rockville, Maryland, USA: GDS and ICF; 2018.
- Francke AL, Smit MC, De Veer AJ, Mistiaen P. Factors influencing the implementation of clinical guidelines for health care professionals: a systematic meta-review. BMC Med Inform Decis Mak. 2008;8:38. doi:https://doi.org/10.1186/1472-6947-8-38.
- Correa VC, Lugo-Agudelo LH, Aguirre-Acevedo DC, Contreras JAP, Borrero AMP, Patiño-Lugo DF, Valencia DAC. Individual, health system, and contextual barriers and facilitators for the implementation of clinical practice guidelines: a systematic metareview. Health Res Policy Syst. 2020;18(1):74. doi:https://doi.org/10.1186/s12961-020-00588-8.
- Zhang X, Zhao K, Bai Z, Yu J, Bai F.Clinical practice guidelines for hypertension: evaluation of quality using the AGREE II instrument. Am J Cardiovasc Drugs. 2016;16(6):439–51. doi:https://doi.org/10.1007/s40256-016-0183-2.
- Al-Ansary LA, Tricco AC, Adi Y, Bawazeer G, Perrier L, Al-Ghonaim M, AlYousefi N, Tashkandi M, Straus SE. A systematic review of recent clinical practice guidelines on the diagnosis, assessment and management of hypertension. PLoS One. 2013;8(1):e53744. doi:https://doi.org/10.1371/journal.pone.0053744.
- Chen Y, Hu S, Wu L, Fang X, Xu W, Shen G.Clinical practice guidelines for hypertension in China: a systematic review of the methodological quality. BMJ Open. 2015;5(7):e008099. doi:https://doi.org/10.1136/bmjopen-2015-008099.
- Álvarez-Vargas ML, Galvez-Olortegui JK, Galvez-Olortegui TV, Sosa-Rosado JM, Camacho-Saavedra LA. Clinical practice guidelines in hypertension: a review. Medwave. 2015 Oct;15(9):e6290. doi:https://doi.org/10.5867/medwave.2015.09.6290.
- Leite-Santos NC, De Melo DO, Mantovani-Silva RA, Gabriel FC, Fornasari GS, Dórea EL, Molino CDGRC, Ribeiro E. Guidelines for hypertension management in primary care: is local adaptation possible?. J Hypertens. 2020;38(10):2059–73. doi:https://doi.org/10.1097/HJH.0000000000002516.
- Hoffmann-Eßer W, Siering U, Neugebauer EA, Brockhaus AC, Lampert U, Eikermann M.Guideline appraisal with AGREE II: systematic review of the current evidence on how users handle the 2 overall assessments. PLoS One. 2017;12(3):e0174831. doi:https://doi.org/10.1371/journal.pone.0174831.
- Molino CGRC, Ribeiro E, Romano-Lieber NS, Stein AT, Melo DO.Methodological quality and transparency of clinical practice guidelines for the pharmacological treatment of non-communicable diseases using the AGREE II instrument: a systematic review protocol. Syst Rev. 2017;6(1):220. doi:https://doi.org/10.1186/s13643-017-0621-5.
- Malaysian Society of Hypertension. Clinical practice guidelines: management of hypertension 5th edition. Malaysia: Malaysian Society of Hypertension; 2018 [accessed 2020 Dec 10]. Available from: http://www.acadmed.org.my/view_file.cfm?fileid=894
- Cardiac Society, Brunei Darussalam. Brunei Darussalam National Hypertension Guideline 2019. 2019 [accessed 2020 Dec 10]. Available from: https://cardiacsociety.org.bn/wp-content/uploads/2019/10/National-Hypertension-Guidelines.pdf
- Ministry of Health, Singapore. Hypertension: MOH clinical practice guidelines 1/2017. Singapore: Ministry of Health, Singapore; 2017 [accessed 2020 Dec 10]. Available from: https://www.moh.gov.sg/docs/librariesprovider4/guidelines/cpg_hypertension-booklet—nov-2017.pdf
- Thai Hypertension Society. 2019 Thai guidelines on the treatment of hypertension. Thailand: Thai Hypertension Society; 2019 [accessed 2020 Dec 10]. Available from: http://www.thaihypertension.org/files/HT%20guideline%202019.with%20watermark.pdf
- Indonesian Society of Hypertension. Treatment of Hypertension Consensus 2019. Jakarta, Indonesia: Indonesian Society of Hypertension; 2019 [accessed 2020 Dec 10]. Available from: http://upload.inash.or.id/cdn/File/Update%20konsensus%202019.pdf
- Vietnam National Heart Association. 2018 VNHA/VSH guidelines on diagnosis and treatment of arterial hypertension in adults. Vietnam: Vietnam National Heart Association; 2018 [accessed 2020 Dec 10]. Available from: http://www.vnha.org.vn/
- Alderson P, Tan T. The use of Cochrane reviews in NICE clinical guidelines. Cochrane Database Syst Rev. 2011;(12):ED000032.
- Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, Fervers B, Graham ID, Hanna SE, Makarski J, et al. Development of the AGREE II, part 1: performance, usefulness and areas for improvement. CMAJ. 2010;182(10):1045–52. doi:https://doi.org/10.1503/cmaj.091714.
- Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, Fervers B, Graham ID, Hanna SE, Makarski J, et al. Development of the AGREE II, part 2: assessment of validity of items and tools to support application. CMAJ. 2010;182(10):E472–E478. doi:https://doi.org/10.1503/cmaj.091716.
- Soni RK, Porter AC, Lash JP, Unruh ML.Health-related quality of life in hypertension, chronic kidney disease, and coexistent chronic health conditions. Adv Chronic Kidney Dis. 2010;17(4):e17–e26. doi:https://doi.org/10.1053/j.ackd.2010.04.002.
- National Institute for Health and Care Excellence (NICE). Hypertension in adults: diagnosis and management. London: NICE; 2019 [accessed 2020 Dec 19]. Available from: https://www.nice.org.uk/guidance/ng136
- World Health Organization. WHO handbook for guideline development, 2nd ed. Geneva: World Health Organization, 2014 [accessed 2020 Dec 19]. https://apps.who.int/iris/handle/10665/145714.
- Scottish Intercollegiate Guidelines Network (SIGN). SIGN 50: a guideline developer’s handbook. Edinburgh: SIGN; 2015 [accessed 2020 Dec 19]. Available from: https://www.sign.ac.uk/assets/sign50_2015.pdf
- National Institute for Health and Care Excellence (NICE). Developing NICE guidelines: the manual. London: NICE; 2014 [accessed 2020 Dec 19]. Available from: https://www.nice.org.uk/process/pmg20/resources/developing-nice-guidelines-the-manual-pdf-72286708700869
- Pronovost PJ.Enhancing physicians’ use of clinical guidelines. JAMA. 2013;310(23):2501–02. doi:https://doi.org/10.1001/jama.2013.281334.
- The Lancet. Managing conflicts of interests in clinical guidelines. Lancet. 2019;394(10200):710.